These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9039920)

  • 1. Treatment of hyperlipidemia in renal transplant recipients.
    Arnadottir M; Berg AL
    Transplantation; 1997 Feb; 63(3):339-45. PubMed ID: 9039920
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperlipidemia in solid organ transplantation.
    Kobashigawa JA; Kasiske BL
    Transplantation; 1997 Feb; 63(3):331-8. PubMed ID: 9039919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipidemia in patients with kidney transplant: causes, effects and management].
    Borges W
    Bol Asoc Med P R; 1995; 87(5-6):116-8. PubMed ID: 8573252
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM; Cheng IK; Tam SC
    Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation.
    Moore RA; Callahan MF; Cody M; Adams PL; Litchford M; Buckner K; Galloway J
    Transplantation; 1990 Jan; 49(1):60-2. PubMed ID: 2301029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary therapy on post renal transplant hyperlipidemia. A prospective study.
    Lal SM; Trivedi HS; Van Stone JC; Ross G
    Int J Artif Organs; 1994 Sep; 17(9):461-5. PubMed ID: 7890433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine.
    Rehman MA; al-Sulaiman MH; Mousa DH; al-Hawas FA; Abdalla AH; Rassoul Z; al-Khader AA
    Transplantation; 1995 Aug; 60(4):397-9. PubMed ID: 7652773
    [No Abstract]   [Full Text] [Related]  

  • 9. Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients.
    Savvidaki E; Koukoulaki M; Benou A; Roumeliotou M; Fourtounas C; Kalliakmani P; Papachristou E; Vlachojannis JG; Goumenos D
    Clin Nephrol; 2011 Feb; 75(2):107-12. PubMed ID: 21255539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipid pattern unifies following renal transplantation in children.
    Müller T; Koeppe S; Arbeiter K; Luckner D; Salzer U; Balzar E; Aufricht C
    Pediatr Nephrol; 2003 Sep; 18(9):939-42. PubMed ID: 12883978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.3. Cardiovascular risks. Hyperlipidaemia.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():26-8. PubMed ID: 12091631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin down regulates mRNA expression of RANTES and CCR5 in posttransplant renal recipients with hyperlipidemia.
    Li Q; Wang D; Wang Y; Xu Q
    Transplant Proc; 2006 Nov; 38(9):2899-904. PubMed ID: 17112859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
    Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia in stable renal transplant recipients.
    Divakar D; Bailey RR; Frampton CM; George PM; Walmsley TA; Murphy J
    Nephron; 1991; 59(3):423-8. PubMed ID: 1758532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on post-transplant dyslipidemia in kidney transplant patients.
    Marubayashi S; Ohdan H; Tashiro H; Tokita D; Onoe T; Hayamizu K; Asahara T; Doi S; Okumoto S; Tanji C; Kawai T; Taniguchi Y; Fukuda Y; Dohi K
    Hiroshima J Med Sci; 2005 Jun; 54(2):39-45. PubMed ID: 15991596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid disorders in renal transplant recipients.
    Ponticelli C; Barbi GL; Cantaluppi A; De Vecchi A; Annoni G; Donati C; Cecchettin M
    Nephron; 1978; 20(4):189-95. PubMed ID: 345139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diet and gemfibrozil on posttransplant hyperlipidemia in renal transplant recipients.
    Sapan M; Ozben B; Yakupoglu G; Suleymanlar G; Ozben T
    J Investig Med; 2009 Feb; 57(2):456-9. PubMed ID: 19174703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
    Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B
    Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidemia and hypertension: impact of steroid withdrawal.
    Van Buren CT
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):30-2. PubMed ID: 8351711
    [No Abstract]   [Full Text] [Related]  

  • 20. Derangement of lipid metabolism and its management in renal transplant patients.
    Keane WF
    Miner Electrolyte Metab; 1997; 23(3-6):166-9. PubMed ID: 9387109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.